What is the recommended misoprostol (prostaglandin E1 analogue) regimen for a 2nd trimester intrauterine fetal death (IUFD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Misoprostol Regimen for Second Trimester Intrauterine Fetal Death (IUFD)

For second trimester IUFD, the recommended misoprostol dosage should be adjusted according to gestational age: 200 mcg vaginally every 6 hours for 13-17 weeks gestation; 100 mcg vaginally every 6 hours for 18-26 weeks gestation; and 25-50 mcg vaginally every 4 hours for gestations beyond 27 weeks. 1

Dosing Recommendations Based on Gestational Age

  • For 13-17 weeks gestation: 200 mcg misoprostol vaginally every 6 hours 1
  • For 18-26 weeks gestation: 100 mcg misoprostol vaginally every 6 hours 1
  • For gestations beyond 27 weeks: 25-50 mcg misoprostol vaginally every 4 hours 1

Special Considerations

  • Lower doses should be used in women with a previous cesarean delivery, and doubling of doses should not occur due to risk of uterine rupture 1, 2
  • For women with scarred uterus, the dose should not exceed 100 mcg per dose 3
  • Vaginal administration is preferred over oral administration as it reduces the induction-expulsion time without increasing side effects 3
  • Clinical monitoring should continue after delivery due to risk of postpartum atony and/or placenta retention 1

Efficacy and Advantages

  • Vaginal misoprostol has been shown to have a shorter induction-to-delivery interval (10.5 ± 5.3 hours) compared to intravenous oxytocin (14 ± 6.8 hours) 4
  • Total hospital stay is significantly lower with misoprostol compared to oxytocin (22.6 ± 9.3 hours vs 35.3 ± 16.4 hours) 4
  • Placenta retention occurs less frequently with misoprostol (5%) compared to oxytocin (20%) 4

Enhanced Protocol Option

  • Pre-treatment with mifepristone (200 mg orally) 24-48 hours before starting misoprostol can:
    • Reduce the induction-to-delivery interval 5
    • Lower the total dose of misoprostol needed 5
    • Eliminate the need for oxytocin augmentation 5

Potential Side Effects and Monitoring

  • Common side effects include nausea, vomiting, diarrhea, fever, and chills 6
  • Doses exceeding 800 mcg are likely to cause more side effects, particularly diarrhea 6
  • Monitor for signs of uterine hyperstimulation, which may require dose adjustment 3
  • Continue clinical monitoring after delivery for potential postpartum hemorrhage 1

Contraindications

  • Misoprostol should be avoided or used with extreme caution in women with previous cesarean delivery due to increased risk of uterine rupture 2, 1
  • When misoprostol must be used in women with scarred uterus, lower doses should be employed 1, 3

References

Research

Misoprostol for intrauterine fetal death.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2007

Guideline

Time Intervals for Misoprostol in Second Trimester Abortions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The use of misoprostol in termination of second-trimester pregnancy.

Taiwanese journal of obstetrics & gynecology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.